Why innovative drug delivery packaging solutions are critical for today’s patients and the importance of leveraging BFS technology to bring new innovation to minimize inaccurate and poor dosing compliance as well as to reduce the risk of microbial contamination and the level of foreign particulates, that could have resulted in billions of dollars in financial consequences and untimely deaths
BFS technology ensures preservative-free unit doses and easy to use unit-dose vials in particular for products requiring an accurate dose delivery as well as reduces human intervention which reduces the risk of microbial contamination and drastically reduces foreign particulates. This conference will discuss new development in drug delivery packaging solutions, including BFS capabilities aimed at precise doses as well as taking a closer look at the future of BFS technology in decontamination and depryogenation that will contribute towards improved manufacturing efficiency and process control in decontamination and depyrogenation of the critical fill zone shroud with BFS technology. For those forward thinking companies involved directly in the business of offering liquid and power stick-packs, liquids in bottles, chewable and effervescent tablet technologies as well as pharmaceutical development, manufacture and life cycle management of BFS technology and products for the pharmaceutical, medical device, diagnostic and clinical industries, this conference is a timely event not to be missed.